AMYCARD LLC is medical equipment company, located in Moscow, Russia.
Founded in 2009 by a team of prominent Russian electrophysiologists and mathematicians, the company was supported by private investment in order to develop innovative methods for noninvasive diagnostics and for interventional treatment of cardiac arrhythmias.  The results of the R&D works are protected by Russian, German and US patents.

In 2009 the Company delivered innovative AMYCARD 01C system for noninvasive EP studies. The system is based on beat-to beat ECG mapping, combined with the CT scan.  AMYCARD 01C measures and reconstructs the real-time isochronal and potential maps on epicardium and endocardium, which allow for  accurate topical diagnostics of cardiac rhythm disturbances. Other applications, such as   diagnostics of ischemia and optimization of CRT are possible.  AMYCARD 01C  is expected to serve more than 200 patients per year in each location.   

 In 2010, the first commercial installation of the fully noninvasive EP laboratory took place.  Russian Ministry of Health included the System in the list of the obligatory medical equipment for heart surgery clinics.  For today over 20 systems were installed in the leading Russian, German and Swiss hospitals. 

Based on its intensive Quality Assurance program, AMYCARD LLC was certified for DIN EN ISO 13485:2007.   Later in 2011, AMYCARD 01C was CE-marked in compliance with MDD 93/42/EEC.

©2011, AMYCARD Design & Development by BDigital | Powered by WebStudio